Canada markets closed

Mindset Pharma Inc. (MSSTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4959-0.0781 (-13.61%)
At close: 03:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.5740
BidN/A x N/A
AskN/A x N/A
Day's Range0.4959 - 0.5632
52 Week Range0.2959 - 1.0718
Avg. Volume46,938
Market Cap43.557M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1790
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A

    The Power Play by The Market Herald Interviews James Lanthier of Mindset Pharma

    VANCOUVER, BC / ACCESSWIRE / January 5, 2022 / The Power Play by The Market Herald has announced the release of a new interview with Mindset Pharma on their latest news.The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

  • CNW Group

    IIROC Trade Resumption - MSET

    Trading resumes in:

  • GlobeNewswire

    The McQuade Center for Strategic Research and Development and Mindset Pharma Collaborate to Develop Psychedelic Medicines

    PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- The McQuade Center for Strategic Research and Development, LLC (MSRD), a member of the global Otsuka family of pharmaceutical companies, and Mindset Pharma Inc. (Mindset) (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) today announce a collaboration that will support the development of psychedelic medicines. MSRD has made a strategic investment to support the discovery and development of novel chemical entity assets of Mindset, a drug discovery and develo